Amniotic fluid and amniotic membrane are young, immune privileged tissues rich with pluripotent and multipotent stem cells, as well as a full range of growth factors and supporting collagen,  proteins, carbohydrates, keratinocytes, and cytokines. For these reasons amnion-derived therapies have shown much promise for treatment of a number of neurological conditions, with a regenerative approach. Clinical success has been well documented to date. Both physicians and researchers alike continue their efforts to unlock the full potential of amnion-derived allografts in neurological treatments.

Improving Outcomes with Amnio Technology

Amnion-derived products have been effective in treating neurological conditions.  Amnion-derived therapies work by releasing essential Growth Factors as well as recruiting stem cells to the site of damage to promote tissue regeneration.  Stem cells are primitive cells that can undergo differentiation to form different types of cells in the body, such as bone, blood, cartilage, tendon, ligaments, etc. These cells are responsible for healing tissue damages by generating new healthy cells. However, with age, the body loses its ability to attract enough stem cells to the site of injury. In this regard, amnio therapy delivers a high concentration of proteins, carbohydrates, cytokines, keratinocytes and growth factors to feed stem cells at the affected area to promote rapid, natural healing.